<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="4" ids="24996">Lactate</z:chebi> is a major energy source for the brain, especially when <z:chebi fb="105" ids="17234">glucose</z:chebi> is not available in sufficient amounts </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we administered <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="16651">L-lactate</z:chebi> (250 mg/kg) to mice before or after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) to test whether <z:chebi fb="4" ids="24996">lactate</z:chebi> can be neuroprotective in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Permanent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 24 h caused a large hemispheric lesion and a severe loss of body weight </plain></SENT>
<SENT sid="3" pm="."><plain>Administration of <z:chebi fb="4" ids="24996">lactate</z:chebi> shortly (15-30 min) before MCAO strongly reduced cell <z:hpo ids='HP_0011420'>death</z:hpo> and <z:hpo ids='HP_0001824'>weight loss</z:hpo>, but only when <z:chebi fb="0" ids="6015">isoflurane</z:chebi> was used for anesthesia </plain></SENT>
<SENT sid="4" pm="."><plain>Under <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> anesthesia, <z:chebi fb="4" ids="24996">lactate</z:chebi> was inactive </plain></SENT>
<SENT sid="5" pm="."><plain>After <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e>, when <z:chebi fb="0" ids="6015">isoflurane</z:chebi> or ketamine-xylazine were used as <z:chebi fb="0" ids="38867">anesthetic drugs</z:chebi>, <z:chebi fb="4" ids="24996">lactate</z:chebi> was effective when given immediately after reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>In separate experiments, we found that plasma <z:chebi fb="4" ids="24996">lactate</z:chebi> levels are also strongly influenced by <z:chebi fb="0" ids="38867">anesthetic drugs</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, <z:chebi fb="0" ids="6015">isoflurane</z:chebi> anesthesia as well as <z:chebi fb="4" ids="24996">lactate</z:chebi> administration caused strongly increased plasma levels of <z:chebi fb="4" ids="24996">lactate</z:chebi> whereas <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> anesthesia significantly reduced plasma <z:chebi fb="4" ids="24996">lactate</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that exogenous <z:chebi fb="4" ids="24996">lactate</z:chebi> is neuroprotective in an in vivo-model of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>, but that its action is strongly influenced by the type of <z:chebi fb="0" ids="38867">anesthetic agent</z:chebi> used </plain></SENT>
</text></document>